PTGS2 and cancer: COX2 is released by cancer-associated fibroblasts (CAFs), type 2 macrophages (M2), and cancer cells to the tumour microenvironment (TME), where it induces cancer stem cell (CSC)-like activity, proliferation, angiogenesis, inflammation, invasion, and metastasis [37].